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studies were not powered to detect sub-group differences.
We explore the use of empirical Bayes methods for esti-
mating sub-group effects while “shrinking” estimates to
account for the greater expected variance associated with
dividing the data. Two example data sets are employed:
(i) an economic evaluation of an Assertive Community
Treatment programme of mentally ill and homeless
persons in Baltimore, USA was analysed by age, race and
clinical sub-groups; and (ii) a multinational clinical trial
of drug therapy for severe heart failure was analysed by
country-speciﬁc sub-groups.
RESULTS: We demonstrate the use of shrinkage estima-
tors in these two examples and show how they lead to
cost-effectiveness estimates for sub-groups that are pulled
toward the overall estimate of cost-effectiveness for the
study. In particular, we show how small sub-groups are
adjusted to a greater extent than larger sub-groups and
we argue that this is appropriate if spurious results are to
be avoided.
CONCLUSIONS: We believe that empirical Bayes or
“shrinkage” estimators provide a potential solution to the
problem that heterogeneity in cost-effectiveness studies is
of prime importance while studies are often under-
powered with respect to potential sub-group analysis.
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OBJECTIVES: To estimate the number of life years lost
due to CHD in Germany. This approach can help to
ascribe importance to effective CHD-prevention.
METHODS: A Markov model following a cohort of
persons at age 30 was used to calculate the number of life
years lost due to CHD. In this model persons currently
developing CHD or experience a sudden cardiac death
now make a transition to a state called “eliminated
CHD”. This construction allows for a poorer survival in
the latter group, which can be attributed to positive cor-
relation between various diseases such as CHD, hyper-
tension and diabetes. Future age-speciﬁc incidence rates
were either based on a combination of risk factor distri-
bution and Framingham risk-equations or on estimations
derived at by ﬁxing future percentages of individuals
dying from CHD.
RESULTS: If CHD could be completely eliminated men
would live between 2.4 and 4.6 years longer and life
expectancy for women would increase by 1.6 to 1.7 years.
Roughly 15% of these life years are lost before the age
of 65. Most sensitive parameters were the incidence rates
and the fatality rates at the ﬁrst CHD-event. The prog-
nosis of those individuals for which the event was pre-
vented also plays an important role: If mortality in this
group is increased by 50%, life years lost fall by one third.
The long-term prognosis of CHD-cases however is com-
parably insensitive.
CONCLUSIONS: CHD is a disease, which has a large
impact on life expectancy especially for men. However
gender differences can only be partly explained by differ-
ences in CHD incidence and CHD mortality. The analy-
sis also shows the effect of inter-disease correlation on the
number of life years lost to CHD.
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OBJECTIVES: We developed a nutrition quality of life
survey (NQOL) to (1) assist clinicians to measure/
monitor/manage the impact of dietary changes on
patients and (2) provide a patient voice in the assessment
process.
METHOD: In Stage 1, we conducted 10 patient and 7
clinician focus in 6 geographically diverse US cities to
identify physical, psychological, and social factors affect-
ing NQOL following recommended dietary modiﬁca-
tions. Each session was transcribed and read by the
investigators and three content consultants. In stage 2, 
we developed a 47-item survey, written at the 5th-6th
grade level, that included 6 item clusters: food impact, 
self image, self efﬁcacy, psychological, interpersonal, and
physical. In stage 3, we mailed the draft survey instru-
ment to each focus group participants, asking the patients
to complete the survey and asking both patients and clin-
icians to suggest improvements.
RESULTS: The 65 patients in the focus groups of stage 1
were 72/28% female/male; age range 18–>65 years;
25/63/12% low/middle/high income; 66/22/11/1% Cau-
casian/African-American/Hispanic/other; and included 7
medical conditions that led to seeking MNT. The 46 clin-
icians in the focus groups were from outpatient, inpatient,
military, public health, and home care practice sites.
Thirty-seven patients, responding to the survey in stage
3, averaged 9 minutes to complete the instrument. Only
one of the 47 items had more than two missing responses.
Based on stage 3 patient and clinician responses, the
survey was modiﬁed to add 4 questions, and improve
syntax and question order. A color format for visually
scoring the survey was also developed.
CONCLUSION: Version 1 of the NQOL is well accepted
by patients and clinicians who participated in focus
groups and responded to the draft survey and provides a
patient-based assessment of the impact of dietary modiﬁ-
cation. Further work will involve psychometric analyses
based on larger population testing, and validity/reliabil-
ity studies.
